Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.

Background The relationship between high sensitivity C-reactive protein and migraine is unclear. The aim of this cross-sectional population-based study was to investigate the association between high sensitivity C-reactive protein and types of headache, and to evaluate the impact of insomnia on this...

Full description

Bibliographic Details
Published in:Cephalalgia
Main Authors: Hagen, Knut, Hopstock, Laila Arnesdatter, Eggen, Anne Elise, Mathiesen, Ellisiv B., Nilsen, Kristian Bernhard
Format: Article in Journal/Newspaper
Language:English
Published: Sage 2019
Subjects:
Online Access:http://hdl.handle.net/11250/2590863
https://doi.org/10.1177/0333102418825370
id ftntnutrondheimi:oai:ntnuopen.ntnu.no:11250/2590863
record_format openpolar
spelling ftntnutrondheimi:oai:ntnuopen.ntnu.no:11250/2590863 2023-05-15T18:34:35+02:00 Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016. Hagen, Knut Hopstock, Laila Arnesdatter Eggen, Anne Elise Mathiesen, Ellisiv B. Nilsen, Kristian Bernhard 2019 http://hdl.handle.net/11250/2590863 https://doi.org/10.1177/0333102418825370 eng eng Sage urn:issn:0333-1024 http://hdl.handle.net/11250/2590863 https://doi.org/10.1177/0333102418825370 cristin:1685770 Cephalalgia Journal article Peer reviewed 2019 ftntnutrondheimi https://doi.org/10.1177/0333102418825370 2019-09-17T06:54:59Z Background The relationship between high sensitivity C-reactive protein and migraine is unclear. The aim of this cross-sectional population-based study was to investigate the association between high sensitivity C-reactive protein and types of headache, and to evaluate the impact of insomnia on this association. Methods A total of 20,486 (63%) out of 32,591 invited, aged ≥40 years or older, participated in the seventh wave of the Tromsø study conducted in 2015–2016 and had valid information on headache, insomnia and high sensitivity C-reactive protein. The influence of insomnia on the association between questionnaire-based diagnoses of headache and elevated high sensitivity C-reactive protein defined as >3.0 mg/L was assessed using multiple logistic regression, estimating prevalence odds ratio with 95% confidence intervals. Results A total of 6290 participants (30.7%) suffered from headache during the last year. Among these, 1736 (8.5%) fulfilled the criteria of migraine, 991 (4.8%) had migraine with aura, 746 (3.6%) migraine without aura (3.8%), and 4554 (22.2%) had non-migrainous headache. In the final multi-adjusted analysis, elevated high sensitivity C-reactive protein was associated with headache (odds ratio 1.10, 95% confidence interval 1.01–1.20), migraine (odds ratio 1.17, 95% confidence interval 1.01–1.35), and migraine with aura (odds ratio 1.23, 95% confidence interval 1.01–1.53). No association was found between elevated high sensitivity C-reactive protein and migraine without aura or non-migrainous headache. The association between high sensitivity C-reactive protein and migraine was strongly dependent on insomnia status. Among individuals with insomnia, elevated high sensitivity C-reactive protein was associated with migraine (odds ratio 1.49, 95% confidence interval 1.02–2.17), and migraine with aura (odds ratio 1.59, 95% confidence interval 1.03–2.45), whereas no such relationship was found among those without insomnia. Conclusions In this cross-sectional study, participants with migraine, in particular migraine with aura, were more likely to have elevated high sensitivity C-reactive protein, evident only among those with insomnia. acceptedVersion © 2019. This is the authors' accepted and refereed manuscript to the article. The final authenticated version is available online at https://journals.sagepub.com/doi/10.1177/0333102418825370. Article in Journal/Newspaper Tromsø NTNU Open Archive (Norwegian University of Science and Technology) Tromsø Cephalalgia 39 8 1022 1029
institution Open Polar
collection NTNU Open Archive (Norwegian University of Science and Technology)
op_collection_id ftntnutrondheimi
language English
description Background The relationship between high sensitivity C-reactive protein and migraine is unclear. The aim of this cross-sectional population-based study was to investigate the association between high sensitivity C-reactive protein and types of headache, and to evaluate the impact of insomnia on this association. Methods A total of 20,486 (63%) out of 32,591 invited, aged ≥40 years or older, participated in the seventh wave of the Tromsø study conducted in 2015–2016 and had valid information on headache, insomnia and high sensitivity C-reactive protein. The influence of insomnia on the association between questionnaire-based diagnoses of headache and elevated high sensitivity C-reactive protein defined as >3.0 mg/L was assessed using multiple logistic regression, estimating prevalence odds ratio with 95% confidence intervals. Results A total of 6290 participants (30.7%) suffered from headache during the last year. Among these, 1736 (8.5%) fulfilled the criteria of migraine, 991 (4.8%) had migraine with aura, 746 (3.6%) migraine without aura (3.8%), and 4554 (22.2%) had non-migrainous headache. In the final multi-adjusted analysis, elevated high sensitivity C-reactive protein was associated with headache (odds ratio 1.10, 95% confidence interval 1.01–1.20), migraine (odds ratio 1.17, 95% confidence interval 1.01–1.35), and migraine with aura (odds ratio 1.23, 95% confidence interval 1.01–1.53). No association was found between elevated high sensitivity C-reactive protein and migraine without aura or non-migrainous headache. The association between high sensitivity C-reactive protein and migraine was strongly dependent on insomnia status. Among individuals with insomnia, elevated high sensitivity C-reactive protein was associated with migraine (odds ratio 1.49, 95% confidence interval 1.02–2.17), and migraine with aura (odds ratio 1.59, 95% confidence interval 1.03–2.45), whereas no such relationship was found among those without insomnia. Conclusions In this cross-sectional study, participants with migraine, in particular migraine with aura, were more likely to have elevated high sensitivity C-reactive protein, evident only among those with insomnia. acceptedVersion © 2019. This is the authors' accepted and refereed manuscript to the article. The final authenticated version is available online at https://journals.sagepub.com/doi/10.1177/0333102418825370.
format Article in Journal/Newspaper
author Hagen, Knut
Hopstock, Laila Arnesdatter
Eggen, Anne Elise
Mathiesen, Ellisiv B.
Nilsen, Kristian Bernhard
spellingShingle Hagen, Knut
Hopstock, Laila Arnesdatter
Eggen, Anne Elise
Mathiesen, Ellisiv B.
Nilsen, Kristian Bernhard
Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.
author_facet Hagen, Knut
Hopstock, Laila Arnesdatter
Eggen, Anne Elise
Mathiesen, Ellisiv B.
Nilsen, Kristian Bernhard
author_sort Hagen, Knut
title Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.
title_short Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.
title_full Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.
title_fullStr Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.
title_full_unstemmed Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.
title_sort does insomnia modify the association between c-reactive protein and migraine? the tromsø study 2015-2016.
publisher Sage
publishDate 2019
url http://hdl.handle.net/11250/2590863
https://doi.org/10.1177/0333102418825370
geographic Tromsø
geographic_facet Tromsø
genre Tromsø
genre_facet Tromsø
op_source Cephalalgia
op_relation urn:issn:0333-1024
http://hdl.handle.net/11250/2590863
https://doi.org/10.1177/0333102418825370
cristin:1685770
op_doi https://doi.org/10.1177/0333102418825370
container_title Cephalalgia
container_volume 39
container_issue 8
container_start_page 1022
op_container_end_page 1029
_version_ 1766219382522904576